India's twelve-year pharmaceutical transformation — from a $14 billion industry to the backbone of global healthcare.
Source: DGCIS India · FY 2025–26 (April 2025 – March 2026)
The Rise
In FY 2014–15, India exported $13.8 billion in pharmaceuticals. Twelve years later, that number has crossed $31 billion — a 124% increase across 487 product lines, reaching more than 200 countries.
DGCIS India, 487 pharma HS codes, FY 2014–15 to 2025–26
Quality
Finished medicines — formulations and biologicals — now account for 75% of India's pharmaceutical exports. The world's pharmacy has moved up the value chain. Vaccine exports alone have reached $1.55 billion, powered by COVID-era capacity repurposed for routine immunisation worldwide.
Access
From the United States to Solomon Islands, from cancer drugs in Havana to dialysis machines in Palau — India supplies affordable medicine to more than 200 countries.
India's Helping Hand
When earthquakes, floods, or health emergencies strike, India responds — not with commerce, but with aid. Since 2023, India has shipped essential medicines, vaccines, surgical supplies, and medical equipment to 55+ countries through the Ministry of External Affairs Rapid Response Cell.
Hope
India's pharmaceutical patent filings have surged from 7,158 in 2014 to 18,668 in 2024 — a 160% increase. What began as generics manufacturing is evolving into research-driven innovation.